Alto Says Investors Use Hindsight In Suit Over Drug Trial

By Katryna Perera · May 6, 2026, 4:45 PM EDT

Alto Neuroscience has urged a California federal judge to toss an investor suit alleging the psychiatric biotech company and its top brass overstated the efficacy of their lead drug candidate for...

To view the full article, register now.
Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Related Sections

Case Information

Case Title

Feldman v. Alto Neuroscience, Inc. et al

Case Number

5:25-cv-06105

Court

California Northern

Nature of Suit

Securities/Commodities

Date Filed

July 21, 2025